Odonate Therapeutics, Inc. Cash
Odonate Therapeutics, Inc. had Cash of $95.03 million as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2021-11-10
- 2021-09-30: Cash $95.03M.
- 2021-06-30: Cash $110.13M.
- 2021-03-31: Cash $133.16M.
- 2020-12-31: Cash $157.26M.
| Period end | Cash |
|---|---|
| 2021-09-30 | $95.03M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $110.13M 10-Q · filed 2021-07-27 |
| 2021-03-31 | $133.16M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $157.26M 10-Q · filed 2021-11-10 |
| 2020-09-30 | $188.26M 10-Q · filed 2020-10-28 |
| 2020-06-30 | $125.42M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $153.12M 10-Q · filed 2020-04-28 |
| 2019-12-31 | $180.46M 10-K · filed 2021-02-23 |
| 2019-09-30 | $204.25M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $206.90M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $112.06M 10-Q · filed 2019-04-25 |
| 2018-12-31 | $139.05M 10-K · filed 2020-02-20 |
| 2018-09-30 | $160.97M 10-Q · filed 2018-10-23 |
| 2018-06-30 | $177.43M 10-Q · filed 2018-07-30 |
| 2018-03-31 | $195.25M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $198.10M 10-K · filed 2019-02-22 |